Views: 0 Author: Site Editor Publish Time: 2026-06-06 Origin: Site
1 formulation constraint needs a finished-SKU plan. “Alcohol-free” must be linked to sensory, appearance, microbiological-control, packaging, stability, label, and claims decisions for the actual product.
2 the product role comes before the ingredient story. Define whether the launch is a daily fresh-breath rinse, a format extension, a concentrated route, or another clearly scoped oral-care role before requesting samples.
3 a formula sample is not a commercial approval. Advance through formula, packaging-compatible, and first-commercial review gates so the approved tablet—or liquid—matches the approved pack and records.
4 packaging is part of the formula decision. Bottle, pump or cap, seal, fill volume, headspace, artwork, transport assumptions, and final instructions can change the SKU that reaches market.
5 claims require product-specific support. Ingredient background, a competitor’s label, or an ethanol-free claim alone cannot justify a finished-product benefit statement.[2] [3]
A usable alcohol-free mouthwash OEM brief defines one product role and the evidence route behind its finished SKU. It should let R&D, quality, packaging, sourcing, and commercial teams understand what to make, how to test it, which pack is being approved, and which market-facing language still needs review.
Begin with a market, channel, intended product role, sensory direction, pack format, planned artwork stage, target launch window, and known claim boundary. The objective is not to turn “no alcohol” into a universal health statement. It is to decide what the brand’s mouthwash needs to demonstrate as a finished product.
Brief area | What the brand should define | What Qiaoerna can scope or record |
|---|---|---|
Product role | One routine, channel, and portfolio role for the launch SKU | Formula direction, sample objective, and review path |
Formula constraints | Alcohol-free requirement, appearance, flavour family, colour, and exclusions | Feasibility discussion and material/formula version control |
Pack route | Fill volume, bottle or other primary pack, closure, seal, label, and transport assumptions | Component review, pack-out assumptions, and packaging-compatible sample plan |
Evidence route | Market, proposed product language, reviewer, and document needs | Test/document checklist and controlled change record |
“Alcohol-free” is useful when the brand can explain its product role and confirm the resulting formula and packaging assumptions. It should not be presented as a judgement that all alcohol-containing rinses are harmful, ineffective, or unsuitable.
A 2021 study compared specified alcohol-containing and alcohol-free mouth rinses in 120 healthy volunteers over 60 days. It reported no statistically or biologically significant adverse clinical responses in the test products at their prescribed use, while also noting that results depend on the products and conditions studied.[1] That is the correct development lesson: evidence for one formulation is not evidence for every other formulation.
For private-label planning, brands may choose an alcohol-free route to align a product role, sensory direction, fragrance/solvent approach, channel plan, or portfolio architecture. Public product collections also show that alcohol-free can function as a shared attribute across multiple flavour intensities, capacities, portable formats, and oral-care roles.[4] That is a market example of SKU architecture—not proof of a Qiaoerna formula or claim.
If the core decision is whether a European portfolio should begin with an alcohol-free or conventional rinse, start with our alcohol-free versus traditional mouthwash guide. Return here when the project needs a formula-and-pack brief.
Define the final product system before approving a first sample: liquid profile, sensory target, appearance, primary pack, use instruction, label route, and launch condition. A one-line request for a “gentle alcohol-free mouthwash” does not tell the factory what a commercial SKU must become.
For example, “mint” is not a sensory brief. Discuss cooling perception, sweetness, flavour persistence, aftertaste, colour/clarity tolerance, and intensity. Similarly, specify fill, component, closure, seal, carton, decoration, market labels, and transport configuration.
An ingredient list does not state how the finished mouthwash must look, taste, remain packaged, or be supported in the target market. The project should therefore record the proposed material route and the product-specific observations or tests that will be reviewed.
Do not write a final claim simply because an ingredient has been researched. Under the EU common criteria, ingredient properties should not imply that the finished cosmetic product has the same properties without adequate and verifiable support for the product and the claim.[2] In the U.S., intended use can be established by label, advertising, online, and other promotional language; changing the wording can change the regulatory analysis.[3]
Sample review should compare defined formula versions and documented sensory or appearance observations.
Review the formula as the customer will receive it: in its intended pack, with the intended use instruction and a defined product role. The first development sample is an evaluation point, not final proof of commercial readiness.
Use a scorecard that identifies sample code, formula version, target market, sensory target, appearance, component assumption, result, and requested change. Keep feedback specific: clarity or opacity, colour consistency, flavour opening, mid-use experience, finish, perceived intensity, and compatibility with the intended product story. Avoid turning subjective feedback into an unverified performance promise.
If the commercial question is whether a foam or liquid mouthwash better fits the launch, use the separate foam versus liquid mouthwash format comparison. If a lower-water shipping or refill route is being considered, compare that route through the concentrated mouthwash category, rather than expanding this page into a full format tutorial.
The commercial SKU is approved as a formula-and-pack configuration, not as a liquid sample alone.
The approved mouthwash is the formula plus its final packaging configuration, not the liquid alone. Move from a formula sample to packaging-compatible review only after the bottle, closure or pump, seal, fill, label, and storage/transport assumptions are defined.
A liquid judged positively in a laboratory container can still require review in the final commercial configuration. Final approval should connect formula version to component specification, fill process, closure/seal route, pack-out, and artwork version.
Approval gate | Brand decision | Records or review inputs |
|---|---|---|
Formula sample | Is the product direction worth advancing? | Sample code, formula version, sensory/appearance feedback, change log |
Packaging-compatible sample | Does the formula proceed with the proposed pack? | Component details, fill assumptions, compatibility/stability plan, artwork stage |
Pilot or first-commercial review | Does the produced and packed SKU match the agreed route? | Batch/pack records, applicable test results, deviation handling, release decision |
Use these gates to link formula, pack, documents, and batch release to the same commercial SKU. Each material, flavour, colour, component, fill, or artwork change should be evaluated against the approved route. The project needs a written plan for the agreed formula and pack: relevant observations or tests, sample coding, review ownership, acceptable criteria, and change handling. Request a schedule separating development, sourcing, sample review, artwork, applicable verification, production, and release.
For supplier-screening, see how to choose the right mouthwash manufacturer. For Europe-specific document and responsibility questions, use our EU private-label mouthwash compliance guide. Neither replaces final market review for the SKU.
Make “alcohol-free” a precise composition statement, then separately review every additional performance or user-benefit claim. A facility document, material file, competitor statement, or broad research article cannot alone prove the final product’s label and advertising language.
Artwork becomes expensive to change when the product role, market route, and evidence boundary were not defined before print approval. Bring the label-copy owner and relevant market reviewer into the brief before final artwork is released.
Request the documents relevant to the final SKU and intended market, such as formula/version records, applicable material and packaging documents, test/review records, batch documentation, label-copy inputs, and release records. Confirm issuer, scope, revision, and applicability. Do not call a facility registration, an ISO certificate, or any document “approval” of the finished product. The product’s intended use and claims remain central to classification in the U.S.[3]
Start with a concise project brief that names the market, product role, sensory direction, packaging route, expected documentation, proposed claims boundary, and launch window. Qiaoerna can translate those inputs into a sample discussion, packaging alignment, and controlled production path.
For the correct product category, visit Mouthwash. For a tailored brief, contact Qiaoerna at admin@qiaoerna.com.cn or use the contact page. Bring your target market and draft product role first; an OEM discussion is more efficient when the team knows which final SKU it is trying to approve.
It is a private-label project that defines an ethanol-free formula direction together with sensory, appearance, packaging, sample, document, claims, and batch-approval requirements for one commercial SKU.
MOQ depends on formula route, flavour, colour, packaging component, fill configuration, artwork, documentation, and whether the product is standard or custom. Request a written MOQ for the exact final SKU.
Start with a written sample objective and formula version. Then progress from formula feedback to packaging-compatible review and, where applicable, pilot or first-commercial approval. Record changes between each gate.
Request market-relevant material, product, packaging, test/review, batch, and label-support documents. Confirm scope, issuer, revision, and final-SKU applicability. A general facility document does not replace final product or claims review.
Formula direction, sensory profile, colour/appearance, fill, component, pack count, artwork, and label language can be discussed for customization. Each approved change should be tracked because it can affect sampling, sourcing, verification, and release.
Choose the product role and channel first, then compare the intended user routine, dose format, packaging, transport, and sample requirements. Use the relevant format pages for a full comparison rather than assuming “alcohol-free” decides the format.
Lead time can be scoped after the formula direction, component, artwork, documentation plan, sample approvals, and production schedule are defined. Request a timeline that separates development, sourcing, verification, production, and release.
Request an Alcohol-Free Mouthwash Project Brief. Send the target market, product role, sensory direction, packaging route, expected claims boundary, and launch window to admin@qiaoerna.com.cn. Qiaoerna can then scope an evidence-aware sample and packaging plan for the relevant commercial SKU.
Author: Xiaoying, R&D Lead, Qiaoerna Biotechnology Co., Ltd.
Technical Review: Qiaoerna Quality & Compliance Team — formula-brief, finished-SKU testing, packaging, document, and claims-boundary review.
[1] Gupta, V., Pant, V. A., Pandey, S., & Pant, A. B. (2021). Efficacy and safety evaluation of alcohol-containing and alcohol-free mouth rinses: A clinicocytological study. Journal of Indian Society of Periodontology, 25(2), 128–132. DOI: 10.4103/jisp.jisp_196_20; PMCID: PMC8041073.
→ Key finding: This 60-day study in 120 healthy volunteers examined specified alcohol-containing and alcohol-free rinses. Its result is product- and condition-specific, not a universal claim for all alcohol-free formulations.
[2] European Commission. (2013). Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products. EUR-Lex.
→ Key finding: Claims should be supported by adequate and verifiable evidence, and ingredient properties should not imply the same properties for a finished product without product-relevant support.
[3] U.S. Food and Drug Administration. (2024). Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) FDA.
→ Regulatory basis: In the U.S., intended use and promotional claims can affect whether a product is a cosmetic, drug, or both; final classification and labeling require market-specific review.
[4] LISTERINE®. (2026). Alcohol-Free Mouthwash Product Collection. Official product collection.
→ Market example: The collection demonstrates how alcohol-free products may be organized by flavour intensity, product role, capacity, and portable format. Its claims and certifications are not evidence for Qiaoerna products.

